CADL
Candel Therapeutics Inc.
$5.38
-$0.20(-3.58%)
43
Overall
60
Value
40
Tech
31
Quality
Market Cap
$307.41M
Volume
837.42K
52W Range
$3.79 - $14.60
Target Price
$20.17
Key Metrics Overview
| Market Cap | $307.41M | P/E Ratio | N/A |
| 52W High | $14.60 | 52W Low | $3.79 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 3.1% | 52W Position | 14.7% |
| Overall Score | 43 | Value Score | 60 |
| Quality Score | 31 | Technical Score | 40 |
Growth Analysis
| EPS Current Est | $-0.4 | EPS Next Est | $-0.48 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CADL | $5.38 | -3.6% | 837.42K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Candel Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW